glp-1 receptor agonists and sglt2 inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Cardiovascular benefits of SGLT2 inhibitors
Description
In this randomized clinical trial ...
Discover clinical trial results and which GLP-1 medication may be right for you.
Includes PREDIMED data and EU health claim context.
These compounds have demonstrated promise as natural glp 1 agonists and may complement dietary and lifestyle strategies for enhanced outcomes
ADDITIONAL DETAILS: Live Probiotics, Prebiotic Fiber, and a Key Postbiotic for Daily Support
FDA updates rules on compounded GLP-1 drugs, impacting patients and providers
